Can the Pathophysiology of Autism be Explained by the Nature of the Discovered Urine Peptides?

References

• Bailey, A., Le Coneur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E. and Rutter, M. (1995) “Autism is a strongly genetic disorder: evidence from a British twin study”, Psychol. Med. 25, 63–77.
   PubMed Web of Science ®Google Scholar
• Banks, W.A., Kastin, A.J., Harrison, L.M. and Zadina, J.E. (1996) “Perinatal treatment of rats with opiates affects the development of blood-brain barrier transport system PTS-1”, Neuroendocrinol. Teratol. 18, 711–715.
   PubMed Web of Science ®Google Scholar
• Bauman, M. (1991 ) “Microscopic neuroanatomic abnormalitites in autism”, Pediatrics 87(Suppl.), 791–796.
   PubMed Web of Science ®Google Scholar
• Bernal, M.E. and Miller, W.H. (1971 ) “Electrodermal and cardiac responses of schizophrenic children to sensory stimuli”, Psychophysiology 7, 155–165.
   Web of Science ®Google Scholar
• Bhatia, K.P., Brown, P., Gregory, Manji, H., Thompson, P.D., Ellison, D.M., et al. (1995) “Progressive myoclonic ataxia associated with coeliac disease. The myoclonus is of cortical origin, but the pathology is in the cerebellum”, Brain 118, 1087–1093.
   PubMed Web of Science ®Google Scholar
• Bohlen, P., Castillo, F., Ling, R. and Guillemin, R. (1980) “An efficient procedure for the separation of peptides from amino acids and salts”, Int. J. Pept. Protein Res. 16, 306–310.
   PubMedGoogle Scholar
• Cade, R.J., Privette, R.M., Fregly, M., Rowland, N., Sun, Z., Zele, V., Wagemaker, H. and Edelstein, C. (2000) “Autism and schizophrenia: intestinal disorders”, Nutr. Neurosci. 2, 57–72.
   Google Scholar
• Campbell, M., Schopler, E., Cueva, J.E. and Hallin, A. (1996) “Treatment of autistic disorder”, J. Am. Acad. Child Adolesc. Psychiatr. 35, 134–143.
   PubMed Web of Science ®Google Scholar
• Chapman, R.W.G., Laidlow, J.M., Colin-Jones, D., Eade, O.E. and Smith, C.L. (1978) “Increased prevalence of epilepsy in coeliac disease”, Br. Med. J. 22 July, 250–251.
   PubMed Web of Science ®Google Scholar
• Chen, L., Hamaguchi, K. and Ogawa, M. (1980) “pCPA reduces both monoaminergic afferents and non-monoaminergic synapses in the cerebral cortex”, Neurosci. Res. 19, 111–115.
   Web of Science ®Google Scholar
• Courchesne, E., Townsend, J. and Saitoh, O. (1994 ) “The brain in infantile autism: posterior fossa structures are abnormal”, Neurology 44, 214–223.
   PubMed Web of Science ®Google Scholar
• D'Eufemia, P., Celli, M., Finnochiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E. and Giardini, O. (1996) “Abnormal intestinal permeability in children with autism”, Acta Paediatr. 85, 1076–1079.
   PubMed Web of Science ®Google Scholar
• Deykin, E.Y. and MacMahon, N. (1979) “The incidence of seizures among children with autistic symptoms”, Am. J. Psychiatr. 136, 1310–1312.
   PubMed Web of Science ®Google Scholar
• Egaas, B., Courchesne, E. and Saitoh (1995) “Reduced size of corpus callosum in autism”, Arch. Neurol. 52, 794–801.
   PubMedGoogle Scholar
• Ermisch, A., Brust, P., Kretzchmar, R. and Buhle, H-J. (1983) “On the blood -brain barrier to peptides (3H) beta-casomorphin-5 uptake by eighteen brain regions in vivo”, J. Neurochem. 41, 1229–1233.
   PubMed Web of Science ®Google Scholar
• Feinberg, I. (1982) “Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?”, J. Psychiatr. Res. 17, 319–334.
   PubMed Web of Science ®Google Scholar
• Frith, U. (1988 ) “Autism: possible clues to the underlying pathology ”, In: Wing, L., ed, Aspects of Autism: Biological Research (Gaskell, The National Autistic Society, London ), pp. 19–30.
   Google Scholar
• Furlano, R.I., Anthony, A., Day, R., Brown, A., McGarvey, L., Tomson, M.A., Davies, S.E., Berelowitz, M., Forbes, A., Wakefield, A.J., Walker-Smith, J.A. and Murch, S.H. (2001) “Colonic CD-8 and g – 8-cell infiltration with epithelial damage in children with autism”, J. Pediatr. 136, 366–372.
   Web of Science ®Google Scholar
• Gardner, M.L.G. (1994 ) “Absorption of intact proteins and peptides ”, In: Johnson, L.R., ed, Physiology of the Gastrointestinal tract, 3rd Ed. (Raven Press, New York ), pp. 1795–1820.
   Google Scholar
• Geissler, A., Andus, T., Roth, M., Kullmann, F., Caesar, I., Held, P., Gross, V., Feuerbach, S. and Schömerich, F. (1995 ) “Focal white- matter lesions in brain of pateints with inflammatory bowel disease”, Lancet 345, 897–989.
   PubMed Web of Science ®Google Scholar
• Gillberg, I.C. and Gillberg, C. (1996) “Autism in immigrants: a population-based study from Swedish rural and urban areas”, J. Intellect. Disabil. Res. 40, 24–31.
   PubMed Web of Science ®Google Scholar
• Gillberg, C., Terenius, L. and Lonnerholm, G. (1985) “Endorphin activity in childhood psychosis: spinal fluid in 24 cases”, Arch. Gen. Psychiatr. 42, 780–783.
   PubMed Web of Science ®Google Scholar
• Gobbi, G., Bouquet, F., Gicco, L., Lambertini, A., Tassinari, C.A., Ventura, L. and Zaniboni, M.G. (1992 ) “Coeliac disease, epilepsy, and cerebral calcifications”, Lancet 340, 439–443.
   PubMed Web of Science ®Google Scholar
• Green, L-A., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L. and Morris, M. (2001) “Oxytocin and autistic disorder: alterations in peptide forms”, Biol. Psychiatr. 50, 609–613.
   PubMed Web of Science ®Google Scholar
• Gschanes, A. and Windisch, M. (1999) “Early postnatal treatment of peptide preparations influences spatial navigation of young and adult rats”, Behav. Brain Res. 100, 161–166.
   PubMed Web of Science ®Google Scholar
• Hadjivassiliou, M., Grünewald, R.A., Chattopadhyay, A.K., Davies-Jones, G.A.B., Gibson, A., Jarratt, J.A., et al. (1998 ) “Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia”, Lancet 352, 1582–1585.
   PubMed Web of Science ®Google Scholar
• Hadjivassiliou, M., Boscolo, S., Davies-Jones, G.A.B., Grünewald, R.A., Not, T., Sanders, D.S., Simpson, J.E., Tongiorgi, E., Williamson, C.A. and Woodroofe, N.M. (2002 ) “The humoral response in the pathogenesis of gluten ataxia”, Neurology 58, 1221–1226.
   PubMed Web of Science ®Google Scholar
• Harper, D.N., Nisbet, R.H. and Siegert, R.J. (1997) “Dietary gluten and learning to attend to redundant stimuli in rats”, Biol. Psychiatr. 42, 1060–1066.
   PubMed Web of Science ®Google Scholar
• Hart, P.E., Gould, S.R., MacSweeney, J.E., Clifton, A. and Schon, F. (1998 ) “Brain white matter lesions in inflammatory bowel disease”, Lancet 351, 1558.
   PubMed Web of Science ®Google Scholar
• Hashimoto, T., Tayama, M., Masahito, M., Sakorama, N., Yoshimoto, T. and Murakawa, K. (1992) “Reduced brain stem size in children with autism”, Brain Dev. 14, 94–97.
   PubMed Web of Science ®Google Scholar
• Hauser, K.F., McLaughlin, P.J. and Zagon, I.S. (1989) “Endogenous opioid systems and the regulation of dendritic growth and spine formation”, J. Comp. Neurobiol. 281, 13–22.
   PubMed Web of Science ®Google Scholar
• Hole, K., Bergslien, A.A., Jorgensen, H., Berge, O-G., Reichelt, K.L. and Trygstad, O.E. (1979 ) “A peptide containing fraction from schizophrenia which stimulates opiate receptors and inhbitis dopamine uptake”, Neuroscience 4, 1139–1147.
   Web of Science ®Google Scholar
• Horvath, K., Papadimitriou, J.C., Rabsztyn, A., Drachenberg, C. and Tildon, J.T. (1999) “Gastrointestinal abnormalities in children with autistic disorder”, J. Pediatr. 135, 559–563.
   PubMed Web of Science ®Google Scholar
• Husby, S., Jensenius, J.C. and Cant, A.J. (1984) “Passage of un-degraded dietary antigen into the blood of healthy adults”, Scand. J. Immunol. 22, 83–92.
   Web of Science ®Google Scholar
• Israngkun, P., Newman, H.A., Patel, S.T., Duruibe, V.A. and Abou-Issa, H. (1986) “Potential biochemical markers for infantile autism”, Neurochem. Pathol. 5, 51–70.
   PubMedGoogle Scholar
• Kahn, A., Rheffat, E., Blum, D., Casimir, G., Duchateau, J., Mozin, J. and Jost, R. (1987 ) “Difficulty in initiating sleep and maintaining sleep associated with cow's milk allergy in infants”, Sleep 10, 116–121.
   PubMed Web of Science ®Google Scholar
• Keller, J. (1997) “Impact of autism-related peptides and 5-HT system manipulations on cortical development and plasticity”, Ist. Annual report for the EU project, BMH4-CT96–0730, pp. 1–10.
   Google Scholar
• Kilshaw, P.J. and Cant, A.J. (1984) “The passage of maternal dietary protein into human breast milk”, Int. Arch. Allergy Appl. Immunol. 75, 8–15.
   PubMedGoogle Scholar
• Kinney, H.C., Burger, P.C., Hurwitz, B.J., Humans, J.C. and Grant, J.P. (1982) “Degeneration of the central nervous system associated with celiac disease”, J. Neurol. Sci. 53, 9–22.
   PubMed Web of Science ®Google Scholar
• Knivsberg, A-M., Reichelt, K.L., Nødland, M. and Høien, T. (1995) “Autistic syndromes and diet: a follow up study”, Scand. J. Edu. Res. 39, 223–236.
   Google Scholar
• Knivsberg, A-M., Reichelt, K.L., Høien, T. and Nødland, M. (2002) “A randomised, controlled study of dietary intervention in Autistic syndromes”, Nutr. Neurosci. 5, 251–261.
   PubMed Web of Science ®Google Scholar
• LaBella, F.S., Geiger, J.D. and Glavin, G.B. (1985 ) “Administrated peptides inhibit the degradation of endogenous peptides, the dilemma of distinguishing direct from indirect effects”, Peptides 6, 645–660.
   PubMed Web of Science ®Google Scholar
• LeBoyer, M., Bouvard, M.P., Lensing, P., Launay, J-M., Tabuteau, F., Arnaud, P., Waller, D., Plumet, M-H., Recasens, C., Kerdelhue, B., Duags, M. and Panksepp, J. (1990) “Opioid excess hyothesis of Autism”, Brain Dysfunct. 3, 285–298.
   Google Scholar
• LeBoyer, M., Bouard, M.P., Racasens, C., Philippe, A., Guillod-Bataille, M., Bondeaux, D., Tabateau, F., Dugas, M., Panksepp, J. and Launoy, J-M. (1994) “Difference between plasma N-and C-terminally directed beta-endorphin immuno-reactivity in infantile autism”, Am. J. Psychiatr. 151, 1797–1801.
   PubMed Web of Science ®Google Scholar
• Lindstrøm, L.H., Nyberg, F., Terenius, L., Bauer, K., Besev, G., Gunne, L.M., Lyrenaas, S., Willdeck-Lund, G. and Lundberg, B. (1984) “CSF and plasma beta-casomorphin-like opioid peptides in post-partum psychosis”, Am. J. Psychiatr. 141, 1059–1066.
   PubMed Web of Science ®Google Scholar
• Lucarelli, S., Frediani, T., Zingoni, A.M., Ferruzzi, F., Giardini, O., Quintieri, F., Barbato, M., D'Eufemia, P. and Cardi, E. (1995) “Food allergy and infantile autism”, Panminerva Med. 37, 137–141.
   PubMed Web of Science ®Google Scholar
• Lucassen, P.L.B., Assendelft, W.J.J., Gubbels, J.W., vanEijk, J.T.M., vanGeldrop, W.J. and Knuistingh Neven, A. (1998) “Effectiveness of treatments for infantile colic: a systematic review”, Br. Med. J. 316, 1563–1569.
   PubMed Web of Science ®Google Scholar
• Mahe, S., Tome, D., Dumontier, A.M. and Desjeux, J.F. (1989 ) “Absorption of intact morphiceptin by diisopropylfluorophosphate-treated rabbit ileum”, Peptides 10, 45–52.
   PubMed Web of Science ®Google Scholar
• Mednick, S.A., Schulsinger, F., Bell, B., Venables, P.H. and Christiansen, K.O. (1974) Genetics, environment and psychopathology (North Holland Press, Amsterdam).
   Google Scholar
• Migliore-Samour, D. and Jollet, P. (1988 ) “Casein, a prohormone with immunostimulating role in the newborns?”, Experientia 44, 88–93.
   Google Scholar
• Nelson, K.B., Grether, J.K., Croen, L.A., Dambrosia, J.M., Dickens, B.F., Jelliffe, L.L., Hansen, R.L. and Phillips, T.M. (2001) “Neuroeptides and neurotophins in neonatal blood of children with autism and mental retardation”, Ann. Neurol. 49, 597–606.
   PubMed Web of Science ®Google Scholar
• Nyberg, F., Liberman, R., Lindstom, L.H., Lyrenaes, S., Koch, G. and Terenius, L. (1989) “Immunoreactive beta-casomorphin-8 in cerebrospinal fluid from pregnant and lactating women: correlation with plasma level”, J. Clin. Endocrinol. Metab. 68, 283–289.
   PubMed Web of Science ®Google Scholar
• Panksepp, J., Normansell, L., Sivily, S., Rossi, J. and Zolovick, A.J. (1978 ) “Casomorphins reduce separation distress in chickens”, Peptides 5, 829–831.
   Web of Science ®Google Scholar
• Paul, K-D., Henker, J., Todt, A. and Eysold, R. (1985) “EEG-Befunde in Zoeliaki-kranken Kindern in Abhængigkeit von der Ernæhrung”, Z. Klin. Med. 40, 439–443.
   Google Scholar
• Pedersen, O.S., Ying, L. and Reichelt, K.L. (1999) “Serotonin uptake stimulating peptide found in plasma of normal individuals and in some autistic urines”, Pept. Res. 53, 641–646.
   Google Scholar
• Persico, A.M., Baldi, A., Reichelt, K-L., Gonzalez, A., Keller, F., (1998) “Serotonin uptake-stimulating peptides extracted from the urines of autistic patients: potential significance for the pathogenesis of autistic disorders”. American Neuroscience Meeting, Los Angeles. abs. No 2.
   Google Scholar
• Persico, A.M., Militerni, R., Brvaccio, C., Schneider, C., Melmed, R., Trillo, S., Montecchi, F., Palermo, M.T., Pascucci, T., puglisi-Allegra, S., Reichelt, K.L., Conciatori, M., Baldi, A. and Keller, F. (2000) “Adenosine deaminase alleles and autistic disorders: case-control and family-based association studies”, Am. J. Med. Genet. 96, 784–790.
   PubMed Web of Science ®Google Scholar
• Persico, A.M., D'Agruma, L., Maiorano, N., Totaro, A., Militerni, R., Bravaccio, C., Wassink, T.H., Schneider, C., Melmed, R., Trilo, S., Montecchi, F., Palermo, M., Pascucci, T., Puglisi-Allegra, S., Reichelt, K.L., Conciatori, M., Marino, R., Quattrocchi, C.C., Baldi, A., Zelante, L., Gasparini, P. and Keller, F. (2001) “Reelin gene alleles and haplotypes as a factor pre-disposing to autistic disorder”, Mol. Psychiatr. 6, 150–159.
   PubMed Web of Science ®Google Scholar
• Piven, J., Arndt, S., Bailey, J. and Andreasen, N. (1996) “Regional Brain enlargement in autism: a magnetic resonance imaging study”, J. Am. Acad. Child Adolesc. Psychiatr. 35, 530–536.
   PubMed Web of Science ®Google Scholar
• Pratesi, R., Gandolfi, L., Friedman, H., Farage, L., DeCastro, C. A.M. and Catassi, C. (1998) “Serum IgA antibodies from patients with coeliac disease react strongly with human brain blood-vessel structures”, Scand. J. Gastroenterol. 33, 817–821.
   PubMed Web of Science ®Google Scholar
• Reichelt, W.H. and Reichelt, K.L. (1997) “The possible role of peptides derived from food proteins in diseases of the nervous system”, In: Gobbi, G., ed, Epilepsy and other Neurological Disorders in Coeliac Disease (John Libbey & Comp., London ), pp. 225–235.
   Google Scholar
• Reichelt, K.L., Saelid, G., Lindback, T. and Boler, J.B. (1986) “Childhood autism: A complex disorder”, Biol. Psychiat. 21, 1279–1290.
   PubMed Web of Science ®Google Scholar
• Reichelt, K.L., Ekrem, J. and Scott, H. (1990) “Gluten, milk proteins and autism: dietary intervention effects on behavior and peptide secretion”, J. Appl. Nutrit. 42, 1–11.
   Google Scholar
• Reichelt, K.L., Knivsberg, A-M., Lind, G. and Nodland, M. (1991) “Probable etiology and possible treatemtn of childhood autism”, Brain Dysfunct. 4, 308–319.
   Google Scholar
• Reichelt, K.L., Pedersen, O.S., Liu, Y., Knivsberg, A.M., and Nødland, M. (1997). “Possible role of peptides, exorphines and serotonin uptake stimulating peptides in autism”. In: Living and learning with Autism (Edit: The Autism Res Unit. University of Sunderland), pp. 221–231.
   Google Scholar
• Reichelt, W.H., E, J., Stensrud, M.B. and Reichelt, K.L. and (1998) “Peptide excretion in Celiac disease”, J. Pediatr. Gastroenterol. Nutrit. 26, 305–309.
   PubMed Web of Science ®Google Scholar
• Remme, J.F., Koetzner, S., Haugland, K., Reichelt, K.L., and Brønstad, G.O. (2001) “Analysis of neuroactive peptides with LC/MS in the urine of autistioc patients”. Proc. 49th Conf Mass Spectrometry and Allied Topics, Chicago, May 27–31, pp. 2–3.
   Google Scholar
• Rimland, B. (1988) “Comparative effects of treatment on child's behaviour”, Autism Res. Rev. Int. 2(suppl. 34B).
   Google Scholar
• Ritvo, E.R., Ornitz, E.M., Eviatar, A., Markham, C.H., Brown, M. and Mason, A. (1969 ) “Decreased post-rotatory nystagmus in early infantile autism”, Neurology 19, 653–658.
   PubMed Web of Science ®Google Scholar
• Ritvo, E., Freeman, B.J., Scheibel, A.B., Duong, T., Robinson, H. and Guthrie, D. (1986) “Lower Purkinje cell counts in cerebella of four autistic subjects: initial findings of the UCLA-NSAC autopsy research report”, Am. J. Psychiatr. 143, 863–866.
   Web of Science ®Google Scholar
• Rogeness, G.A., Javors, M.A. and Pliszka, S.R. (1992) “Neurochemistry and child and adolescent psychiatry”, J. Am. Acad. Child Adolesc. Psychiatr. 31, 765–781.
   PubMed Web of Science ®Google Scholar
• Rosenblum, S.M., Ariock, J.R., Krug, D.A., Stubbs, E.G., Young, N.B. and Pelson, R.O. (1980) “Auditory brainstem evoked responses in autistic children”, J. Autism Dev. Disord., 215–225.
   PubMed Web of Science ®Google Scholar
• Scifo, R., Cioni, M., Batticane, N., Tirolo, C., Testa, N., Quattropani, M.C., Morale, M.C., Gallo, F. and Marchetti, B. (1996 ) “Opioidimmune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone”, Ann. Ist. Super. Sanita 32, 351–359.
   PubMedGoogle Scholar
• Shanahan, M.R., Venturini, A.J., Daiss, J.L. and Friedman, A.E. (2000) “Peptide diagnostic markers for human disorders”, Eur. Patent Appl. EP 0 969 015 A2 1–44, 1–44.
   Google Scholar
• Shattock, R. (1995). “Can dietary intervention be used successfully as a therapy for Autism?” In Psychological Perspectives in Autism. (Edit: The Autism Res Unit. University of Sunderland), pp. 203–206.
   Google Scholar
• Shattock, P., Kennedy, A., Rowell, F. and Berney, T. (1990) “Role of neuropeptides in autism and their relationship with classical neurotransmitters”, Brain Dysfunct. 3, 328–345.
   Google Scholar
• Siggins, G.R., Henriksen, S.J., Chavkin, C. and Gruol, D. (1986) “Opioid peptides and epileptogenesis in the limbic system: cellular mechanisms”, Adv. Neurol., 501–512.
   PubMedGoogle Scholar
• Singh, V.K. (1995) “Neuropeptides as native immune modulators”, Prog. Drug Res. 45, 10–31.
   Google Scholar
• Singh, V.K., Lin, S.X., Newell, E. and Nelson, C. (2002) “Abnormal measles-mumps-rubella antiboides and CNS autoimmunity in children with autism”, J. Biomed. Sci. 9, 359–364.
   PubMed Web of Science ®Google Scholar
• Stubbs, E.G., Crawford, M.L., Burger, D.R. and Vandenbark, A.A. (1977) “Depressed lymphocyte responsiveness in autistic children”, J. Autism Child. Schizophr. 7, 49–55.
   PubMedGoogle Scholar
• Sun, Z. and Cade, J.R. (1999 ) “A peptide found in schizophrenia and autism causes behavioral changes in rats”, Autism 3, 85–95.
   Google Scholar
• Sun, Z., Cade, R.J., Fregly, M.J. and Privette, R.M. (1999 ) “Beta-casomorphin induces Fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism”, Autism 3, 67–83.
   Google Scholar
• Tenconi, B., DiGiulio, A.M., Donadoni, M.L., Montegazza, P. and Gorio, A. (1991) “Perinatal exposure to opiates alters reactive pruning and regeneration of serotoninergic neurones”, Brain Dysfunct. 4, 49–50.
   Google Scholar
• Thibault, L., Coulon, J-F., Roberg, J., Craig, K.A., Meador-Woodruff, J.H., Goldman, R. and Green, J.F. (1988) “Changes in serum amino acids content and dopamine beta-hydroxylase activity and brain neuro-transmitter interaction in cats fed casein with and without gluten”, J. Clin. Biochem. Nutrit. 4, 209–221.
   Web of Science ®Google Scholar
• Torrente, F., Ashwood, P., Day, R., Machado, N., Furlano, R.I., Anthony, A., Davies, S.E., Wakefield, A.J., Thomson, M.A., Walker-Smith, J.A. and Murch, S.H. (2002) “Small intestinal eneropathy with epithelial IgG and complement deposition in children with regressive autism”, Mol. Psychiatr. 7, 375–382.
   PubMed Web of Science ®Google Scholar
• Troncone, R., Scarcella, A., Donatiello, A., Cannataro, P., Tarabusco, A. and Aurichio, S. (1987) “Passage of gliadin into human breast milk”, Acta Paediatr. Scand. 76, 453–456.
   PubMed Web of Science ®Google Scholar
• Wakefield, A.J., Anthony, A., Murch, S.H., Thomson, M., Montgomery, S.M., Davies, S., O'Leary, J.J., Berelowitz, M. and Walker-Smith, J.A. (2000) “Enterocolitis in children with developmental disorders”, Am. J. Gastroenterol. 95, 2285–2295.
   PubMed Web of Science ®Google Scholar
• Waring, R.H. and Ngong, J.M. (1993). Sulphate metabolism in allergy-induced autism: relevance to the disease etiology. In Biological perspectives in Autism (Edit: The Autism Res Unit. University of Sunderland), pp. 25–33.
   Google Scholar
• Watanabe, Y., Kojima-Kumatsu, T., Iwaki-Egawa, A. and Fujimoto, Y. (1993) “Increased excretion of proline-containing peptides in dipeptidyl peptidase IV-deficient rats”, Res. Commun. Chem. Pathol. Pharmacol. 81, 323–350.
   PubMedGoogle Scholar
• Whiteley, P., Rodgers, J., Savery, D. and Shattock, P. (1999 ) “A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings”, Autism 3, 45–65.
   Google Scholar
• Zagon, I.S. and McLaughlin, P.J. (1987) “Endogenous opioid systems regulate cell proliferation in the developing rat brain”, Brain Res. 412, 68–72.
   PubMed Web of Science ®Google Scholar